Blood samples were collected in tubes without additives containing 3.2% sodium citrate (Vacutainer, Becton-Dickinson, Franklin Selleck SGC-CBP30 Lakes, NJ USA). Samples were centrifuged within 1 h at 2500 g for 20 min, to obtain platelet-poor plasma. The plasmas were immediately tested. Moreover, plasma and serum samples were separated and stored in multiple aliquots at
−80°C for subsequent testing. All coagulation parameters (PT, aPTT, fibrinogen, AT, D-dimer, PC, PS, FVIII) were assayed by clotting, chromogenic and immunological methods on fully-automated ACL TOP analyzer using HemosIL® commercial kits (Instrumentation Laboratory Company, Bedford, MA USA). Abnormal values were defined by the clinical laboratory or manufacturer’s assay. Plasma levels of TAT and F1 + 2 were measured by enzyme-linked immunosorbent assay Enzygnost® Cilengitide clinical trial TAT micro and Enzygnost® F1 + 2 mono kits, respectively (Siemens Healthcare Diagnostics Inc, NY USA), according to the manufacturer’s instructions. Both assays employ the quantitative sandwich enzyme immunoassay technique. All samples showing values above the standard curve
were re-tested with appropriate dilutions. Plasma levels of PAI-1 were measured with the enzyme-linked immunosorbent assay Asserachrom® kit (Diagnostica Stago, Asnieres, France), according to the manufacturer’s instructions. Plasma p-selectina levels were determined by Human sP-Selectin enzyme immunoassay (R&D Systems, Inc Minneapolis, MN USA), according to the manufacturer’s instructions, employing the quantitative sandwich enzyme immunoassay technique.
Statistical analysis Data were analyzed with Statistical Package for the Social Sciences (SPSS) 14.0 software. Continuous and categorical variables were Androgen Receptor antagonist expressed as the mean ± standard deviation or standard error and as frequency values selleck compound and proportions, respectively. Pearson’s chi-square test was used to assess possible differences in dichotomous variables between the various groups examined. The means of normally distributed data were compared with the Student’s t-test. In other cases, the groups were compared with the Mann-Whitney’s U test. P values of the tests were adjusted using the Bonferroni method. Paired samples were analyzed by t-test and Wilcoxon Signed Ranks Test. Multiple linear regression was used in order to test the effect of anaesthesia, surgery and clinical characteristics of patients on changes of prothrombotic markers 24 h post-surgery (T2 time). A p-value of <0.05 was considered statistically significant. Results Clinical characteristics of the patients The clinical characteristics of the patients enrolled in the study are reported in Tables 1 and 2.